SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-017504
Filing Date
2019-09-09
Accepted
2019-09-09 16:23:54
Documents
2
Period of Report
2019-09-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k090519_delmarpharma.htm 8-K 20648
2 AMENDMENT TO THE 2017 OMNIBUS EQUITY INCENTIVE PLAN OF DELMAR PHARMACEUTICALS, I f8k090519ex10-1_delmar.htm EX-10.1 7226
  Complete submission text file 0001213900-19-017504.txt   29184
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 191083302
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1